Literature DB >> 24312760

Determination of comparative minimum inhibitory concentration (MIC) of bacteriocins produced by enterococci for selected isolates of multi-antibiotic resistant Enterococcus spp.

Maryam Hassan1, Yousef Javadzadeh, Farzaneh Lotfipour, Rajabali Badomchi.   

Abstract

INTRODUCTION: The occurrence of multi-antibiotic resistance among enterococci is a prevalent clinical problem worldwide and continues to get serious due to the lack of efficient therapeutic options by the time. In this regards, prokaryotic antimicrobial peptides with bactericidal or bacteriostatic activity which are directed against bacterial strains closely related to producer strains looks one of the promising alternative to conventional antibiotics.
METHODS: The antibiotic susceptibility pattern of 20 clinical isolates of enterococci was evaluated and subsequently the isolates were screened for antibacterial activity against three different indicator strains. The efficacy of potential bacteriocinogenic isolates were assayed against multi-antibiotic resistant Enterococcus spp. by comparative minimum inhibitory concentration (MIC).
RESULTS: Antibiotic resistant pattern of enterococcal isolates demonstrated that multi-antibiotic resistant to conventional antibiotics were significantly high and the prevalent pattern of resistance was combination of gentamicin, streptomycin, chloramphenicol and vancomycin. In addition, the data from comparative MIC showed the noticeable activity of selected potential bacteriocinogenic strains against pathogenic enterococci.
CONCLUSION: The present survey may address the potential applicability of antimicrobial peptides in alleviating the problems of antibiotic resistance.

Entities:  

Keywords:  MIC; antibiotic resistant; bacteriocin; enterococci; microtiter

Year:  2011        PMID: 24312760      PMCID: PMC3845979          DOI: 10.5681/apb.2011.011

Source DB:  PubMed          Journal:  Adv Pharm Bull        ISSN: 2228-5881


  41 in total

Review 1.  Functionality of enterococci in dairy products.

Authors:  Giorgio Giraffa
Journal:  Int J Food Microbiol       Date:  2003-12-01       Impact factor: 5.277

2.  In vitro antibacterial activity of different endodontic irrigants.

Authors:  Claudio Poggio; Marco Colombo; Andrea Scribante; Dario Sforza; Stefano Bianchi
Journal:  Dent Traumatol       Date:  2011-11-03       Impact factor: 3.333

Review 3.  Antimicrobial peptides: general overview and clinical implications in human health and disease.

Authors:  Eduardo Guaní-Guerra; Teresa Santos-Mendoza; Saúl O Lugo-Reyes; Luis M Terán
Journal:  Clin Immunol       Date:  2010-01-29       Impact factor: 3.969

4.  Drug resistant enterococci in a south Indian hospital.

Authors:  K G Bhat; C Paul; N C Ananthakrishna
Journal:  Trop Doct       Date:  1998-04       Impact factor: 0.731

5.  Broad-spectrum antibacterial activity by a novel abiogenic peptide mimic.

Authors:  Klaus Nüsslein; Lachelle Arnt; Jason Rennie; Cullen Owens; Gregory N Tew
Journal:  Microbiology       Date:  2006-07       Impact factor: 2.777

6.  vanA and vanB incorporate into an endemic ampicillin-resistant vancomycin-sensitive Enterococcus faecium strain: effect on interpretation of clonality.

Authors:  J P Suppola; E Kolho; S Salmenlinna; E Tarkka; J Vuopio-Varkila; M Vaara
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

Review 7.  New strategies for novel antibiotics: peptides targeting bacterial cell membranes.

Authors:  Karl Lohner
Journal:  Gen Physiol Biophys       Date:  2009-06       Impact factor: 1.512

Review 8.  Antimicrobial peptides: primeval molecules or future drugs?

Authors:  Brian M Peters; Mark E Shirtliff; Mary Ann Jabra-Rizk
Journal:  PLoS Pathog       Date:  2010-10-28       Impact factor: 6.823

Review 9.  Therapeutic options for infections due to vancomycin-resistant enterococci.

Authors:  Jiun-Ling Wang; Po-Ren Hsueh
Journal:  Expert Opin Pharmacother       Date:  2009-04       Impact factor: 3.889

Review 10.  The role of antimicrobial peptides in preventing multidrug-resistant bacterial infections and biofilm formation.

Authors:  Seong-Cheol Park; Yoonkyung Park; Kyung-Soo Hahm
Journal:  Int J Mol Sci       Date:  2011-09-16       Impact factor: 5.923

View more
  1 in total

1.  Discovery of novel isatin-based thiosemicarbazones: synthesis, antibacterial, antifungal, and antimycobacterial screening.

Authors:  Maryam Hassan; Ramtin Ghaffari; Soroush Sardari; Yekta Farmahini Farahani; Shohreh Mohebbi
Journal:  Res Pharm Sci       Date:  2020-07-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.